BIOLASE (NASDAQ:BIOL) stock price plummeted 30% during early hours on Thursday as the company priced an underwritten public offering of 75K units, with each unit consisting of one share of BIOLASE's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results